Daniela Arosio

14PUBLICATIONS
54CO-AUTHORS
Proteins and peptidesMedical devicesGlycoconjugatesNanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 23, 2026
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy.

Francesco Merlino, Valentina Pagliara, Vincenzo Maria D'Amore

|Dec 16, 2024
Synthesis and Preliminary Evaluation of Tanshinone Mimic Conjugates for Mechanism of Action Studies.

Giulia Assoni, Ágata Sofia Assunção Carreira, Matteo Tomiello

|Jan 03, 2023
RGD Cyclopeptide Equipped with a Lysine-Engaging Salicylaldehyde Showing Enhanced Integrin Affinity and Cell Detachment Potency.

Giovanni Sacco, Daniela Arosio, Mayra Paolillo

|Apr 23, 2022
Squalene-Based Nano-Assemblies Improve the Pro-Autophagic Activity of Trehalose.

Giulia Frapporti, Eleonora Colombo, Hazem Ahmed

|Dec 19, 2020
Cyclic RGD and isoDGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic (cis-β-ACPC) Scaffolds.

Silvia Panzeri, Daniela Arosio, Silvia Gazzola

|Jul 08, 2020
Shifting Towards αV β6 Integrin Ligands Using Novel Aminoproline-Based Cyclic Peptidomimetics.

Kelly Bugatti, Agostino Bruno, Daniela Arosio

Pageof 3